Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post- Chernobyl papillary thyroid carcinomas: Biological, phenotypic, and clinical implications

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 1093-1103

  Rabes, Hartmut M ^a   Demidchik, Evgenij P ^b   Sidorow, Juri D ^b   Lengfelder, Edmund ^a   Beimfohr, Claudia ^a   Hoelzel, Dieter ^a   Klugbauer, Sabine ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Thyroid Cancer Center   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CHERNOBYL ACCIDENT; DISEASE ASSOCIATION; FEMALE; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RADIATION EXPOSURE; THYROID PAPILLARY CARCINOMA;

ACCIDENTS, RADIATION; ADOLESCENT; AGE FACTORS; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; DROSOPHILA PROTEINS; FEMALE; GENE REARRANGEMENT; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKA; SEX FACTORS; THYROID NEOPLASMS; TIME FACTORS; VARIATION (GENETICS);

EID: 0034016275     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Ron, E., Modan, B., Preston, D., Alfandary, E., Stovall, M., and Boice, J. Thyroid neoplasia following low-dose radiation in childhood. Radiat. Res., 120: 516-531, 1989.
2. Favus, M. J., Schneider, A. B., Stachura, M. E., Arnold, J. E., Ryo, U. Y., Pinsky, S. M., Colman, M., Arnold, M. J., and Frohman, L. A. Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N. Engl. J. Med., 294: 1019-1025, 1976.
3. Schneider, A. B., Ron, E., Lubin, J., Stovall, M., and Gierlowski, T. C. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J. Clin. Endocrinol. Metab., 77: 362-369, 1993.
4. Shore, R. E., Hildreth, N., Dvoretsky, P., Andersen, E., Moseson, M., and Pasternack, B. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland. Am. J. Epidemiol., 137: 1068-1080, 1993.
5. Hancock, S. L., Cox, R. S., and McDougall, I. R. Thyroid diseases after treatment of Hodgkin's disease. N. Engl. J. Med., 325: 599-605, 1991.
6. Prentice, R. L., Kato, H., Yoshimoto, K., and Mason, M. Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents. Natl. Cancer. Inst. Monogr., 62: 207-212, 1982.
7. Ezaki, H., Takeichi, N., and Yoshimoto, Y. Thyroid cancer: epidemiological study of thyroid cancer in A-bomb survivors from extended life span study cohort in Hiroshima. J. Radiat. Res. (Tokyo), 32 (Suppl.): 193-200, 1991.
8. Thompson, D. E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., Sugimoto, S., Ikeda, T., and Terasaki, M. Cancer incidence in atomic bomb survivors. II. Solid tumors, 1958-1987. Radiat. Res., 137: S17-S67, 1994.
9. Cronkite, E. P., Bond, V. P., and Conard, R. A. Medical effects of exposure of human beings to fallout radiation from a thermonuclear explosion. Stem Cells (Dayton), 13 (Suppl. 1): 49-57, 1995.
10. Ron, E., Lubin, J. H., Shore, R. E., Mabuchi, K., Modan, B., Pottern, L. M., Schneider, A. B., Tucker, M. A., and Boice, J. D. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res., 141: 259-277, 1995.
11. Baverstock, K., Egloff, B., Pinchera, A., Ruchti, C., and Williams, D. Thyroid cancer after Chernobyl. Nature (Lond.), 359: 21-22, 1992.
12. Kazakov, V., S., Demidchik, E. P., and Astakhova, L. N. Thyroid cancer after Chernobyl. Nature (Lond.), 359: 21, 1992.
13. Nagataki, S., Ashizawa, K., and Yamashita, S. Cause of childhood thyroid cancer after the Chernobyl accident. Thyroid, 8: 115-117, 1998.
14. Jacob, P., Kenigsberg, Y., Zvonova, I., Goulko, G., Buglova, E., Heidenreich, W. F., Golovneva, A., Bratilova, A. A., Drozdovitch, V., Kruk, J., Pochtennaja, G. T., Balonov, M., Demidchik, E. P., and Paretzke, H. G. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br. J. Cancer, 80: 1461-1469, 1999.
15. Astakhova, L. N., Anspaugh, L. R., Beebe, G. W., Bouville, A., Drozdovitch, V. V., Garber, V., Gavrilin, Y. I., Khrouch, V. T., Kuvshinnikov, A. V., Kuzmenkov, Y. N., Minenko, V. P., Moschik, K. V., Nalivko, A. S., Robbins, J., Shemiakina, E. V., Shinkarev, S., Tochitskaya, S. I., and Waclawiw, M. A. Chernobyl-related thyroid cancer in children of Belarus: a case-control study. Radiat. Res., 15: 349-356, 1998.
16. Cardis, E., Amoros, E., Kesminiene, A., Malakhova, I. V., Poliakov, S. M., Piliptsevitch, N. N., Demidchik, E. P., Astakhova, L. N., Ivanov, V. K., Konogorov, A. P., Parshkov, E. M., and Tsyb, A. F. Observed and predicted thyroid cancer incidence following the Chernobyl accident. Evidence for factors influencing susceptibility to radiation induced thyroid cancer. In: G. Thomas, A. Karaoglou, and E. D. Williams (eds.), Radiation and Thyroid Cancer, pp. 395-405. Singapore: World Scientific Publishing Co., 1999.
17. Furmanchuk, A. W., Averkin, J. I., Egloff, B., Ruchti, C., Abelin, T., Schäppi, W., and Korotkevich, E. A. Pathomorphological findings in thyroid cancers of children from the Republic of Belarus: a study of 86 cases occurring between 1986 ('post-Chernobyl') and 1991. Histopathology, 21: 401-408, 1992.
18. Nikiforov, Y. E., and Gnepp, D. R. Pediatric thyroid cancer after the Chernobyl disaster. Cancer (Phila.), 74: 748-766, 1994.
19. Nikiforov, Y. E., and Gnepp, D. R. Pathomorphology of thyroid gland lesions associated with radiation exposure: the Chernobyl experience and review of the literature. Adv. Anat. Pathol., 6: 78-91, 1999.
20. Pacini, F., Vorontsova, T., Demidchik, E. P., Molinaro, E., Agate, L., Romei, C., Shavrova, E., Cherstvoy, E. D., Ivashkevitch, Y., Kuchinskaya, E., Schlumberger, M., Ronga, G., Filesi, M., and Pinchera, A. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J. Clin. Endocrinol. Metab., 82: 3563-3569, 1997.
21. Rabes, H. M., and Klugbauer, S. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement. Recent Results Cancer Res., 154: 248-264, 1998.
22. Nikiforov, Y. E., Nikiforova, M. N., Gnepp, D. R., and Fagin, J. A. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene, 13: 687-693, 1996.
23. Smida, J., Zitzelsberger, H., Kellerer, A. M., Lehmann, L., Minkus, G., Negele, T., Speisberg, F., Hieber, L., Demidchik, E. P., Lengfelder, E., and Bauchinger, M. p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history. Int. J. Cancer, 73: 802-807, 1997.
24. Suchy, B., Waldmann, V., Klugbauer, S., and Rabes, H. M. Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours. Br. J. Cancer, 77: 952-955, 1998.
25. Sα gene mutations in childhood thyroid tumors after Chemobyl in contrast to sporadic adult thyroid neoplasia. Cancer Res., 57: 2358-2361, 1997.
26. Takahashi, M., Ritz, J., and Cooper, G. M. Activation of a novel human transforming gene ret, by DNA rearrangement. Cell, 42: 581-588, 1985.
27. Avantaggiato, V., Dathan, N. A., Grieco, M., Fabien, N., Lazzaro, D., Fusco, A., Simeone, A., and Santoro, M. Developmental expression of the RET proto oncogene. Cell Growth Diff., 5: 305-311, 1994.
28. Santoro, M., Rosati, R., Grieco, M., Berlingieri, M. T., D'Amato, G. L., de Franciscis, V., and Fusco. A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene, 5: 1595-1598, 1990.
29. Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., and Parada, L. F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (Washington DC), 252: 554-558, 1991.
30. Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Porta, G., Fusco, A., and Vecchio, G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinoma. Cell, 60: 557-563, 1990.
31. Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Della Porta, G., and Pierotti, M. A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol., 13: 358-366, 1993.
32. Bongarzone, I., Butti, M. G., Coronelli, S., Borrello, M. G., Santoro, M., Mondellini, P., Pilotti, S., Fusco, A., Della Porta, G., and Pierotti, M. A. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res., 54: 2979-2985, 1994.
33. Santoro, M., Dathan, N. A., Berlingieri, M. T., Bongarzone, I., Paulin, C., Grieco, M., Pierotti, M. A., Vecchio, G., and Fusco, A. Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto oncogene in a human thyroid papillary carcinoma. Oncogene, 9: 509-516, 1994.
34. 70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA, 93: 5517-5521, 1996.
35. Pierotti, M. A., Bongarzone, I., Borrello, M. G., Greco, A., Pilotti, S., and Sozzi, G. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer, 16: 1-14, 1996.
36. Bongarzone, I., Vigneri, P., Mariani, L., Collini, P., Pilotti, S., and Pierotti, M. A. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin. Cancer Res., 4: 223-228, 1998.
37. Hermanek, P., Hutter, R. V. P., Sobin, L. H., Wagner, G., and Winekind, C. TNM-Atlas, 4, Auflage, pp. 64-69. Berlin: Springer, 1998.
38. Hedinger, C., Williams, E. D., and Sobin, L. H. Histological typing of thyroid tumours. In: International Histological Classification of Tumours, Ed. 2, No. 11. Berlin: Springer, 1988.
39. Klugbauer, S., Lengfelder, E., Demidchik, E. P., and Rabes, H. M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene, 11: 2459-2467, 1995.
40. Klugbauer, S., Demidchik, E. P., Lengfelder, E., and Rabes, H. M. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5. Cancer Res., 58: 198-203, 1998.
41. Klugbauer, S., and Rabes, H. M. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene, 18: 4388-4393, 1999.
42. Beimfohr, C., Klugbauer, S., Demidchik, E. P., Lengfelder, E., and Rabes, H. M. NTRK1 rearrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident. Int. J. Cancer, 80: 842-847, 1999.
43. Klugbauer, S., Demidchik, E. P., Lengfelder, E., and Rabes, H. M. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl. Oncogene, 16: 671-675, 1998.
44. Klugbauer, S., Lengfelder, E., Demidchik, E. P., and Rabes, H. M. A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene, 12: 1099-1102, 1996.
45. Sanger, F., Niklen, S., and Coulson, A. R. DNA sequencing with chain-termination inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
46. Rabes, H. M., and Klugbauer, S. Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement. Verh. Dtsch. Ges. Pathol., 81: 139-144, 1997.
47. Bongarzone, I., Fugazzola, L., Vigneri, P., Mariani, L., Mondellini, P., Pacini, F., Basolo, F., Pinchera, A., Pilotti, S., and Pierotti, M. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab., 81: 2006-2009, 1996.
48. Soares, J., Limbert, E., and Sobrinho-Simões, M. Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases. Pathol. Res. Pract., 185: 200-206, 1989.
49. Fujimoto, Y., Obara, T., Ito, Y., Kodama, T., Aiba, M., and Yamaguchi, K. Diffuse sclerosing variant of papillary carcinoma of the thyroid. Cancer (Phila.), 66: 2306-2312, 1990.
50. Jacob, P., Goulko, G., Heidenreich, W. F., Likhtarev, I., Kairo, I., Tronko, N. D., Bogdanova, T. I., Kenigsberg, J., Buglova, E., Drozdovitch, V., Golovneva, A., Demidchik, E. P., Balonov, M., Zvonova, L. and Beral, V. Thyroid cancer risk to children calculated. Nature (Lond.), 392: 31-32, 1998.
51. Rabes, H. M., Müller, L., Hartmann, A., Kerler, R., and Schuster, C. Cell-cycle dependent initiation of ATPase-deficient populations in adult rat liver by a single dose of N-methyl-N-nitrosourea. Cancer Res., 46: 645-650, 1986.
52. Rabes, H. M., Bücher, T., Hartmann, A., Linke, I., and Dünnwald, H. Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res., 42: 3220-3227, 1982.
53. Nikiforov, Y. E., Rowland, J. M., Bove, K. E., Monforte-Munoz, H., and Fagin, J. A. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res., 57: 1690-1694, 1997.
54. Smida, J., Salassidis, K., Hieber, L., Zitzelsberger, H., Kellerer, A., Demidchik, E. P., Negele, T., Speisberg, F., Lengfelder, E., Werner, M., and Bauchinger, M. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int. J. Cancer, 80: 32-38, 1999.
55. Fugazzola, L., Pilotti, S., Pinchera, A., Vorontsova, T. V., Mondellini, P., Bongarzone, I., Greco, A., Astakhova, L., Butti, M. G., Demidchik, E. P., Pacini, F., and Pierotti, M. A. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res., 55: 5617-5620, 1995.
56. Bounacer, A., Wicker, R., Caillou, B., Cailleux, A. F., Sarasin, A., Schlumberger, M., and Suarez, H. G. High prevalence of activating ret proto-oncogene rearrangements in thyroid tumors from patients who had received external radiation. Oncogene, 15: 1263-1273, 1997.
57. Friedberg, E. C., Walker, G. C., and Siede, W. DNA repair and mutagenesis. Washington: ASM Press, 1995.
58. Pierotti, M. A., Santoro, M., Jenkins, R. B., Sozzi, G., Bongarzone, I., Grieco, M., Monzini, N., Miozzo, M., Herrmann, M. A., Fusco, A., Hay, I. D., Della Porta, G., and Vecchio, G. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc. Natl. Acad. Sci. USA, 89: 1616-1620, 1992.
59. Minoletti, F., Butti, M. G., Coronelli, S., Miozzo, M., Sozzi, G., Pilotti, S., Tunnacliffe, A., Pierotti, M. A., and Bongarzone, I. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosomes Cancer, 11: 51-57, 1994.
60. TPC oncogene in human thyroid cancers. Oncogene, 7: 1331-1337, 1992.
61. Sugg, S., Zheng, L., Rosen, I., Freeman, J., Ezzat, S., and Asa, S. RET/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J. Clin. Endocrinol. Metab., 81: 3360-3365, 1996.
62. Tang, M-J., Worley, D., Sanicola, M., and Dressler, G. R. The RET-glial cell-derived neurotrophic factor (GDNF) pathway stimulates migration and chemoattraction of epithelial cells. J. Cell Biol., 142: 1337-1345, 1998.
63. Powell, D. J., Jr., Russell, J., Nibu, K., Li, G., Rhee, E., Liao, M., Goldstein, M., Keane, W. M., Santoro, M., Fusco, A., and Rothstein, J. L. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res., 58: 5523-5528, 1998.
64. Jhiang, S., M., Sagartz, J. E., Tong, Q., Parker-Thornburg, J., Capen, C. C., Cho, J. Y., Xing, S., and Ledent, C. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology, 137: 375-378, 1996.
65. Santoro, M., Chiappetta, G., Cerrato, A., Salvatore, D., Zhang, L., Manzo, G., Picone, A., Portella, G., Santelli, G., Vecchio, G., and Fusco, A. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene, 12: 1821-1826, 1996.
66. Pisarchik, A. V., Ermak, G., Fomicheva, V., Kartel, N. A., and Figge, J. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus. Thyroid, 8: 133-139, 1998.
67. Pisarchik, A. V., Ermak, G., Demidchik, E. P., Mikhalevich, L. S., Kartel, N. A., and Figge, J. Low prevalence of the RET/PTC3r1 rearrangement in a series of papillary thyroid carcinomas presenting in Belarus ten years post-Chernobyl. Thyroid, 8: 1003-1008, 1998.
68. Bascom, R. A., Srinivasan, S., and Nussbaum, R. L. Identification and characterization of golgin-84, a novel Golgi integral membrane protein with a cytoplasmic coiled-coil domain. J. Biol. Chem., 274: 2953-2962, 1999.
69. Thénot, S., Henriquet, C., Rochefort, H., and Cavaillès, V. Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. J. Biol. Chem., 272: 12062-12068, 1997.
70. van Weering, D. H. J., and Bos, J. L. Signal transduction by the receptor tyrosine kinase RET. Recent Results Cancer Res., 154: 271-281, 1998.